It was a huge amount of money for a teenager to imagine having, but what Denali Brehmer had to do to get the cash couldn’t have been more shocking. Brehmer was being offered $9 million by a ...
US-based biotechnology company Denali Therapeutics has reported that a Phase II/III trial of DNL343 for amyotrophic lateral sclerosis (ALS) failed to meet its primary endpoint. The primary ...